Clinical Characteristics of Hyponatremia by Yano, Mayumi et al.
ORIGINAL
Clinical characteristics of hyponatremia in patients receiving
nutrition support : A cross-sectional study evaluated by 
bioelectrical impedance analysis
Mayumi Yano1, Arisa Inoue1, Akiyo Toda2, Michiko Takahashi3, Makoto Usami2, and Yasuhiro Hamada1
1Department of Therapeutic Nutrition, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan, 
2Department of Clinical Nutrition and Dietetics, Konan Women’s University, Kobe, Japan, 3Department of Nutrition, Division of Diabetes 
and Endocrinology Department of Internal Medicine, Kobe University Hospital, Kobe, Japan
Abstract : Background & aims : We investigated the contributing factors of hyponatremia in patients on nutri-
tion support using bioelectrical impedance analysis (BIA). Methods : Thirty patients administered enteral or 
parenteral nutrition support for at least 72 hours were studied. We collected nutritional and electrolyte intake, 
serum biochemical parameters, and body composition measured by BIA. Patients were classified into two groups 
according to their serum sodium levels : (1) Normanatremia group, 135–145 mEq / L (n = 18) and (2) Hyponatremia 
group, less than 135 mEq / L (n = 12), and their characteristics were analyzed. Results : There were no significant 
differences between the Normonatremia and Hyponatremia groups in terms of energy, protein, and sodium in-
take. Serum biochemical parameters other than serum sodium and chloride levels were comparable between 
the two groups. On the other hand, the ratio of extracellular water to total body water (ECW / TBW) obtained by 
BIA was significantly higher in the Hyponatremia group than in the Normonatremia group. Further, an elevated 
ECW / TBW significantly and negatively correlated with serum albumin level. Conclusions : Regardless of sodium 
intake, higher ECW / TBW was associated with hyponatremia in patients on nutrition support. ECW / TBW may 
be an important clinical parameter relevant to the nutritional care of hyponatremia. J. Med. Invest. 68 : 112-118, 
February, 2021
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INTRODUCTION
 
Hyponatremia, the most common electrolyte abnormality in 
hospitalized patients (1), has recently emerged as a risk factor 
for mortality (2-10). An increased morbidity and mortality rate 
has been observed in hyponatremia in hemodialysis patients 
(2-4) and patients with medical conditions such as heart failure 
(5), myocardial infarction (6), stroke (7), liver cirrhosis (8), pul-
monary embolism (9), and cancer (10). In the clinical setting, 
many patients receiving nutrition support have these diseases, 
and hyponatremia has been often seen in these patients. Indeed, 
we reported that approximately 50% of hospitalized patients on 
nutrition support had hyponatremia (11).
Hyponatremia might point to a “frail phenotype” or “volume 
overload.” In hemodialysis patients, hyponatremia has been 
associated with low body mass index (BMI) (2), intradialytic 
weight loss (2), low lean tissue index (3), and low serum albu-
min level (2, 4). In addition, hyponatremia has been associated 
with weight loss in patients on peritoneal dialysis (12) and with 
disease severity in patients with pulmonary embolism (9). As 
highlighted by previous studies, hyponatremia is a marker of 
underlying severe disease that carries a poor prognosis (13), 
and hyponatremia itself may contribute to adverse outcomes 
such as mortality and heightened consumption of health care 
resource (14, 15). Therefore, the treatment of hyponatremia is 
very important.
In the clinical treatment of hyponatremia in patients with 
edema, overly rapid corrections of hyponatremia may worsen 
the hyponatremia condition. Also, inappropriate treatment of 
hyponatremia may lead to destructive consequences such as 
osmotic demyelination syndrome that leads to permanent brain 
damage or even death (1, 16). Hence, appropriate assessment of 
the causative factor of hyponatremia is important for the subse-
quent management of hyponatremia and avoidance of treatment 
pitfalls.
Bioelectrical impedance analysis (BIA) is widely used in the 
clinical setting for the evaluation of nutritional status and fluid 
status (17, 18). BIA is a simple, noninvasive, rapid, portable, 
and convenient method, which indirectly estimates the body 
composition and fluid distribution by sending a weak electric 
current throughout the body (19). Hyponatremia has been often 
seen in patients receiving nutrition support (11), but no study 
has revealed the clinical characteristics of hyponatremia in 
patients on nutrition support. Therefore, we investigated the 
contributing factor of hyponatremia in patients on nutrition 
support using BIA. Our study aimed to reveal the clinical char-
acteristics of hyponatremia in patients on nutrition support and 
to play a constructive part in the appropriate nutritional care of 
hyponatremia. 
MATERIALS AND METHODS
Study Design and Participants
We performed a cross-sectional study of patients who were 
admitted in general ward at Kobe University Hospital from 
October 2011 to September 2012. Patients were included if 
they were administered enteral nutrition (EN) or parenteral 
nutrition (PN) with the same quality and quantity for at least 72 
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hours by the Nutrition Support Team (NST). Patients prescribed 
with oral intake were excluded. Based on the criteria established 
by the Ministry of Health, Labor and Welfare, nutrition supports 
are provided by the NST to the following patients : patients with 
hypoalbuminemia (serum albumin ≤ 3.0 g / dL) and who are 
identified “at risk for malnutrition” status by subjective global 
assessment (20) on risk screening, on EN or PN, and any patient 
who is expected to improve nutritional status by receiving NST 
interventions.
Based on the European Society of Parenteral and Enteral 
Nutrition guidelines (19), the following criteria were used to ex-
clude the patients from this study : patients with an amputation, 
abnormal physical structure, and ascites or noticeable edema. A 
total of 30 patients were included in the final statistical analysis.
We collected nutritional intake, electrolyte intake, serum 
biochemical parameters, and results of BIA. Patients were clas-
sified into two groups according to their serum sodium levels : (1) 
Normonatremia group, 135–145 mEq / L (n = 18) and (2) Hypo-
natremia group, less than 135 mEq / L (n = 12), and their charac-
teristics were analyzed. The study protocol was approved by the 
Ethics Committee of Kobe University School of Medicine (No. 
1277) and complied with the Declaration of Helsinki. All patients 
were included in this study after providing informed consent. 
Serum Chemistry
Fasting blood samples were collected by using an antecubital 
vein puncture sample from each patient. Blood was collected 
using 10 mL tubes and centrifuged at 1500 × g for 10 min at 4°C. 
Complete blood counts were determined immediately after blood 
collection. Biochemical parameters were measured immediately 
after centrifugation. Hematological parameters and biochem-
ical assessments were determined in the hospital laboratory 
using commercially available test kits. In brief, complete blood 
counts were measured using the XE2100 Hematology analyzer 
(Sysmex, Kobe, Japan). Biochemical parameters were measured 
using the TBA200FR NEO Automated Analyzer (Toshiba Med-
ical Systems, Tochigi, Japan). 
BIA 
The body composition of each patient was assessed using the 
InBody S20 multi-frequency analyzer (Biospace, Tokyo, Japan) 
because BIA is a noninvasive and commonly used method for 
estimating body composition. The analyzer used an 8-point 
tactile electrode system that measures the total and segmental 
impedance and phase angle of alternating electric current at 
four different frequencies. It was used according to the manufac-
turer’s instructions.
Statistical Analysis
All statistical analyses were performed using SPSS 24.0 (IBM 
Corp., Armonk, NY). Continuous variables were expressed as 
mean ± standard deviation (parametric variables) or median 
and interquartile range (non-parametric variables). Normality of 
distribution was assessed with Shapiro-Wilk tests. Differences 
between groups were analyzed with the two-tail Student’s t-test 
for independent variables in case of parametric distribution, 
while the Mann–Whitney U-test was used in case on non-para-
metric distribution. Categorical variables were described using 
proportions and were analyzed with the χ2 test. Correlations 
were analyzed using Pearson’s correlation analysis. P-values 
< 0.05 were considered statistically significant.
RESULTS
Patients Characteristics
We included 30 patients (Normonatremia vs. Hyponatre-
mia : n = 18 vs. 12), and their demographic characteristics are 
shown in Table 1. There were no significant differences in 
demographic characteristics between the Normonatremia and 
Hyponatremia groups. Approximately 50% or more patients in 
the two groups received a combination of PN and EN. The most 
common underlying disease in the two groups was malignancy. 
The prescribed medication which affected serum sodium level 
was Loop-diuretics alone.
Nutritional Intake・Electrolyte Intake
Sodium intake seemed to be higher in the Hyponatremia 
group than in the Normonatremia group but no significant dif-
ferences were observed (Figure 1). Table 2 shows the nutritional 
and electrolyte intake calculated from the total amount of PN 
and EN. The ratio of energy to body weight (BW), protein to BW, 
and sodium to BW were comparable between the two groups. 
Biochemical Parameters
In the Normonatremia and Hyponatremia groups, the serum 
sodium levels were 140 ± 3 mEq / L and 132 ± 2 mEq / L, respec-
tively, while the serum chloride levels were 103 ± 4 mEq / L and 
98 ± 4 mEq / L, respectively. Serum potassium, total protein, 
serum albumin, blood urea nitrogen, serum creatinine, total 
lymphocyte count, C-reactive protein, and estimated glomerular 
filtration rate were comparable between the two groups (Table 3).
 
Body Composition Analysis
The ratio of skeletal muscle mass to BW, body fat mass to BW, 
body cell mass to BW, and lean body mass to BW were compara-
ble between the two groups (Table 4). As shown in Figure 2, the 
ratio of extracellular water to total body water (ECW / TBW) was 
significantly higher in the Hyponatremia group than in the Nor-
monatremia group 0.420 ± 0.009 and 0.407 ± 0.011, respectively 
(P < 0.01). In addition, ECW / TBW in the two groups was higher 
than the standard value (0.36–0.39).
 
Figure 1.　Nutritional intake・Electrolyte intake
EN, enteral nutrition; PN, parenteral nutrition.
Although sodium intake seemed to be higher in the Hyponatremia 
group than in the Normonatremia group, there were no significant 
differences.







Sex Men/Woman 13 / 5 10 / 2 NS a
Age year 70.0 (62.8-76.8) 72.0 (69.3-81.8) NS b
Body height cm 159.8 ± 8.0 160.6 ± 9.3 NS c
Body weight kg 54.0 ± 15.3 50.6 ± 9.7 NS c
BMI kg / m2 21.0 ± 5.3 19.6 ± 3.3 NS c
Routes of nutrition support n (%)
PN only 5 (27.8%) 6 (50%) NS a
EN only 1 (5.6%) 0 (0%) NS a
PN + EN 12 (66.7%) 6 (50%) NS a
Underlying disease n (%)
Malignancy 9 (50.0%) 4 (33.3%) NS a
Clinical stage
Ⅲd 2 (11.1%) 1 (8.3%) NS a
Ⅳd 1 (5.6%) 2 (16.7%) NS a
Postoperative 5 (27.8%) 0 (0%) NS a
Unknown 1 (5.6%) 1 (8.3%) NS a
Cancer diagnosis
Head 0 (0%) 1 (8.3%) NS a
Pharyngenal / laryngeal 2 (11.1%) 0 (0%) NS a
Lung 2 (11.1%) 1 (8.3%) NS a
Esophageal 2 (11.1%) 1 (8.3%) NS a
Gastric 2 (11.1%) 1 (8.3%) NS a
Duodenal 1(5.6%) 0 (0%) NS a
Chronic kidney disease 6 (33.3%) 3 (25.0%) NS a
Hemodialysis 2 (11.1%) 1 (8.3%) NS a
Diabetes 3 (16.7%) 4 (33.3%) NS a
Cirrhosis 2 (11.1%) 1 (8.3%) NS a
Cerebrovascular disease 2 (11.1%) 2 (16.7%) NS a
Cardiovascular disease 0 (0%) 2 (16.7%) NS a
Medication n (%)
Loop-diuretics 2 (11.1%) 1 (8.3%) NS a
BMI, Body mass index ; PN, parenteral nutrition ; EN, enteral nutrition ; NS, not significant.




dEach patient was staged according to the TNM classification by the Union for International Cancer Control and/or 
Japanese General Rules for Clinical and Pathological Classification of Cancer.






energy kcal / day 1262 ± 487 1136 ± 515 NS a
energy / BW kcal / kg (BW) / day 24.4 ± 10.3 23.5 ± 12.4 NS a
protein g / day 49.6 ± 20.5 38.7 ± 21.5 NS a
protein / BW g / kg (BW) / day 1.0 ± 0.5 0.8 ± 0.5 NS a
sodium mEq / day 127.7 (100.3-180.0) 162.7 (101.7-245.1) NS b
sodium / BW mEq / kg (BW) / day 3.1 ± 2.0 3.5 ± 1.6 NS a
BW, Body weight ; NS, not significant.
Data are presented as mean ± standard deviation, median (interquartile amplitude).
aStudent’s t-tests.
bMann–Whitney U-test.
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Correlation of ECW / TBW with Serum Albumin Level in All Patients
The relationships between ECW / TBW and serum albumin 
level were investigated using partial correlation accounting for 
the influence of age. As shown in Figure 3, ECW / TBW had a 
significant negative correlation with serum albumin level (r 
= −0.643, P < 0.01). Meanwhile, ECW content and the ratio of 
ECW to BW had no correlation with serum albumin level (r = 
0.004, P = 0.984 ; r = 0.237, P = 0.208).
 
DISCUSSION
In this study, we found that ECW / TBW was significantly 
higher in the Hyponatremia group than in the Normonatremia 
group, regardless of sodium intake. Furthermore, an elevated 
ECW / TBW significantly and negatively correlated with serum 
albumin level as would be expected with patients with excess 
ECW. Thus, ECW / TBW may be an important clinical parame-
ter for the evaluation of hyponatremia and fluid status.
Hyponatremia has been associated with low BMI (2), weight 
loss (2, 12), low lean tissue index (3), and low serum albumin 
(2, 4) in patients with different diseases, which might result 







Sodium mEq / L 140 ± 3 132 ± 2 P < 0.01 a
Potassium mEq / L 4.3 ± 0.5 4.0 ± 0.8 NS a
Chloride mEq / L 103 ± 4 98 ± 4 P < 0.01 a
Total protein g / dL 5.6 ± 1.0 5.9 ± 1.0 NS a
Albumin g / dL 2.5 ± 0.5 2.2 ± 0.5 NS a
Blood urea nitrogen mg / dL 21.0 (13.0-26.3) 13.0 (11.3-23.8) NS b
Creatinine mg / dL 0.75 (0.58-1.24) 0.62 (0.45-1.11) NS b 
Total lymphocyte count cell / μL 765 (470-886) 744 (373-1124) NS b
C-reactive protein mg / dL 2.5 (1.4-5.7) 4.1 (2.0-6.0) NS b 
estimated glomerular filtration rate ml/min / 1.73 m2 74.4 ± 39.6 86.7 ± 48.2 NS a
NS, not significant.
Data are presented as mean ± standard deviation, median (interquartile amplitude).
aStudent’s t-tests.
bMann–Whitney U-test.






Skeletal muscle mass kg / kg (BW) 0.41 ± 0.06 0.40 ± 0.06 NS a
Body fat mass kg / kg (BW) 0.21 (0.14-0.24) 0.21 (0.15-0.25) NS b
Body cell mass kg / kg (BW) 0.50 (0.49-0.53) 0.49 (0.42-0.52) NS b
Lean body mass kg / kg (BW) 0.79 (0.76-0.86) 0.79 (0.75-0.85) NS  b
ECW L 12.6 ± 2.8 12.1 ± 2.4 NS a
TBW L 31.0 ± 6.9 28.9 ± 5.7 NS a
ECW / TBW 0.407 ± 0.001 0.420 ± 0.009 P < 0.01 a
BW, Body weight ; NS, not significant
Data are presented as mean ± standard deviation, median (interquartile amplitude).
aStudent’s t-tests.
bMann–Whitney U-test.
Figure 2.　Comparison of ECW / TBW between the Normonatremia 
group and the Hyponatremia group
ECW / TBW, the ratio of extracellular water to total body water.
*P < 0.01, Student’s t-tests (Normonatremia group vs Hyponatremia 
group).
ECW / TBW was significantly higher in the Hyponatremia group 
than in the Normonatremia group 0.420 ± 0.009 and 0.407 ± 0.011, 
respectively (P < 0.01). ECW / TBW standard value (0.36–0.39).
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Normonatremia and Hyponatremia groups was higher than the 
standard value, which indicated that fluid imbalance between 
intracellular water (ICW) and ECW was present in the two 
groups. The cause of fluid volume imbalance is multifactorial 
and may be associated with systemic inflammation, hypoalbu-
minemia, capillary leakage, and a decline in lean and / or fat 
tissue mass (21-24).These factors may have contributed to an 
elevated ECW / TBW in the two groups. Moreover, the higher 
ratio of ECW / TBW was associated with hyponatremia, regard-
less sodium intake. Literature suggests that hyponatremia with 
chronically ill patients is caused by impaired renal free water 
excretion which results from inappropriate release of vasopres-
sin such as syndrome of inappropriate antidiuretic hormone and 
reset osmostat (25). These diseases may have further exacerbat-
ed the fluid volume imbalance. However, since they were not di-
agnosed in this study, it was unclear whether they contributed to 
hyponatremia. Although hyponatremia is often multifactorial, 
very interestingly, ECW / TBW showed a significant difference 
between the two groups.  
Previous researchers have shown that the BIA data are asso-
ciated with patient’s nutritional status or clinical outcomes (17, 
18). In particular, ECW / TBW, which represents fluid status, has 
also been found to be a good prognostic factor for diseases such 
as acute heart failure (26), renal disease (27), liver disease (28) , 
and malignancy (29). The subjects of this study included patients 
with systemic inflammation such as malignancy or chronic kid-
ney disease. The higher ECW / TBW ratio in these patients has 
been reported to have common characteristics as follows. First, 
fluid retention, such as pleural effusion, ascites, or edema in the 
peripheral extremities is often seen in patients with malignancy 
(30) or chronic kidney disease (31) and is generally associated 
with disease progression, which is indicated as ECW excess. 
Second, fluid volume imbalance may be closely associated with 
systemic inflammation, hypoalbuminemia, vascular permea-
bility, protein catabolism, and muscle wasting (21-24). Notably, 
systemic inflammation seems to play a pivotal role in the fluid 
volume imbalance by the following mechanisms : Hypoalbumin-
emia and increased vascular permeability caused by systemic 
inflammation will enhance extravascular fluid shift, resulting 
in ECW volume overload (21, 22). In addition, increased protein 
catabolism and muscle wasting caused by systemic inflamma-
tion could deplete body cell mass, which eventually leads to the 
decrease in ICW, and relative increase in ECW / TBW (23, 24). 
In this study, an elevated ECW / TBW showed a significant 
negative correlation with serum albumin level even after ac-
counting for age. In contrast, ECW content and the ratio of 
ECW to BW had no correlation with serum albumin level. These 
findings would support the clinical picture of relative excess 
ECW due to fluid volume imbalance, regardless of age. Previous 
studies reported that patients with decreased ICW and relatively 
increased ECW (ie, relative increase in ECW / TBW) were sus-
ceptible to volume overload (29, 32). Therefore, ECW / TBW may 
be useful as an important clinical parameter for the evaluation 
of hyponatremia and fluid status.
The final treatment for hyponatremia in patients receiving 
nutritional support is corrective treatment for serum sodium 
concentration and fluid balance to improve their prognosis. 
Based on our results, we suggest ECW / TBW as an indicator of 
fluid balance. Although clinical assessment of fluid status has 
been applied as one of the diagnostic parameters of algorithm 
for the diagnosis of hyponatremia (1), the method for the assess-
ment has not been clarified. The indicator of fluid balance using 
ECW / TBW may help the evaluation of hyponatremia in the 
clinical setting.
One of the clinical practice pitfalls, which could endanger 
hyponatremic patients, is overly rapid correction of hyponatre-
mia. NST patients often receive PN management. They often 
already have a fluid volume imbalance. Excessive serum sodium 
correction with PN can cause a rapid rise in serum sodium 
level, eventually resulting in overcorrection of hyponatremia, 
and exposes the patients to harmful risks such as edema and 
worsening of hyponatremia. Therefore, we suggest prioritizing 
corrective treatment for fluid balance before sodium replenish-
ment. In other words, we suggest interventions aimed at improv-
ing ECW / TBW ratio, rather than interventions aimed solely 
at increasing serum sodium concentration. Assessment of fluid 
status by ECW / TBW may prevent excessive serum sodium cor-
rection and may help the evaluation of hyponatremia in patients 
on nutrition support. 
Our study had some limitations. First, our study was limit-
ed by its observational nature, which allowed us to establish 
associations, but not causality. Further studies are needed to 
demonstrate causality between hyponatremia and fluid volume 
imbalance. Second, it was not possible to classify the patients 
according to ECW / TBW owing to the small sample size. It would 
be better to compare the ECW / TBW with various indicators 
such as nutritional status and clinical outcomes and to monitor 
them in clinical practice.
In conclusion, regardless of sodium intake, higher ECW / TBW 
was associated with hyponatremia in patients on nutrition 
support. Further, an elevated ECW / TBW significantly and 
negatively correlated with serum albumin level, as would be 
expected with patients with excess ECW. ECW / TBW may be an 




Figure 3.　Correlation of ECW/TBW with serum albumin level in all 
patients
ECW / TBW, the ratio of extracellular water to total body water.
ECW / TBW had a significant negative correlation with serum albumin 
level (r = −0.643, P < 0.01).
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